分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation

Zan Xiangyi, Li Shuyan, Wei Shixiong, Gao Liping, Zhao Lanting, Yan Xiaoxia, Zhao Yan, Shi Junnian, Wang Yuping, Liu Rong, Zhang Yuanyi, Wan Yixin, Zhou Yongning

Journal:Frontiers in Oncology

IF:5.74

DOI:10.3389/fonc.2022.707525

PMID:35280763

Published:2022-02-24

research field:神经科学分子生物学表观转录组学脑卒中病理学

Abstract

Activation of EGFR is a major risk factor for non-small cell lung cancer (NSCLC). Understanding the molecular events promoting EGFR activation can help us gain more insights into the progression of NSCLC. In this study, we demonstrate that collagen type VIII alpha 1 chain (COL8A1), an extracellular matrix component, was overexpressed in NSCLC. In NSCLC cells, knockdown of COL8A1 suppressed cell growth, cycle progression, and migration, and induced cell apoptosis. While COL8A1 overexpression promoted cell proliferation and inhibited cell apoptosis. In addition, we found that COL8A1 depletion reduced interferon response signaling and downregulated (IFIT1) and interferon-induced proteins with tetratricopeptide repeats 3 (IFIT3). Moreover, we indicated that COL8A1 could upregulate IFIT1 and IFIT3 mediated EGFR activation in vitro and in vivo. Lastly, there was a positive correlation among COL8A1, IFIT1, and IFIT3 expression, and EGFR activity in patients with NSCLC. Overall, our data demonstrate that COL8A1 contributes to NSCLC proliferation and invasion through EGFR activation, dependent on IFIT1 and IFIT3 expression.

本文使用的Yeasen产品

购物车
客服
转染试用